Sodium lauryl sulphate increases tiludronate paracellular transport using human epithelial caco-2 monolayers
- 29 August 1995
- journal article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 123 (1), 71-83
- https://doi.org/10.1016/0378-5173(95)00041-g
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Importance of the paracellular pathway for the transport of a new bisphosphonate using the human CACO-2 monolayers modelBiochemical Pharmacology, 1993
- Epithelial Transport of Drugs in Cell Culture. VIII: Effects of Sodium Dodecyl Sulfate on Cell Membrane and Tight Junction Permeability in Human Intestinal Epithelial (Caco-2) CellsJournal of Pharmaceutical Sciences, 1993
- Sodium Caprate Elicits Dilatations in Human Intestinal Tight Junctions and Enhances Drug Absorption by the Paracellular RoutePharmaceutical Research, 1993
- Epithelial Transport of Drugs in Cell Culture. VII: Effects of Pharmaceutical Surfactant Excipients and Bile Acids on Transepithelial Permeability in Monolayers of Human Intestinal Epithelial (Caco‐2) CellsJournal of Pharmaceutical Sciences, 1992
- Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochemical and Biophysical Research Communications, 1991
- Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2Biochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- Epithelial Transport Of Drugs In Cell Culture. I: A Model For Studying The Passive Diffusion Of Drugs Over Intestinal Absorbtive (Caco-2) CellsJournal of Pharmaceutical Sciences, 1990
- The Use of Cultured Epithelial and Endothelial Cells for Drug Transport and Metabolism StudiesPharmaceutical Research, 1990
- Liquid penetration as a method of assessing the wettability and surface energy of pharmaceutical powdersJournal of Pharmacy and Pharmacology, 1986
- Absorption Potential: Estimating the Fraction Absorbed for Orally Administered CompoundsJournal of Pharmaceutical Sciences, 1985